| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1,682.49× | 1,682.49× | 601.04× | 286.73× | 79.05× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| — | −0.00× | −0.01× | −0.01× | −0.03× | ||
| 0.01× | 0.01× | 0.02× | 0.02× | 0.05× | ||
| 1.16× | 1.16× | 0.80× | 0.45× | 0.31× | ||
| 8.10× | 8.10× | −10.72× | 0.69× | 15.94× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 79.05 | 286.73 | 601.04 | 1,682.49 | 1,682.49 | |
| Working Capital Turnover | -0.03 | -0.01 | -0.01 | -0.00 | — | |
| Asset Turnover | 0.05 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Cash Conversion (CFO/Net Income) | 0.31 | 0.45 | 0.80 | 1.16 | 1.16 | |
| CFO/EBITDA | 15.94 | 0.69 | -10.72 | 8.10 | 8.10 |